| Literature DB >> 27886887 |
Abstract
Despite increasing knowledge about the risk factors and clinical findings of nonarteritic anterior ischemic optic neuropathy (NAION), the treatment of this optic neuropathy has remained limited and without clear evidence-based benefit. Historical treatments of NAION are reviewed, beginning with the Ischemic Optic Neuropathy Decompression Trial. More recent treatments are placed within the historical context and illustrate the need for evidence-based therapy for ischemic optic neuropathy. Copyright ÂEntities:
Keywords: Ischemic Optic Neuropathy Decompression Trial (IONDT); Ischemic optic neuropathy; Nonarteritic anterior ischemic optic neuropathy (NAION); Obstructive sleep apnea syndrome (OSAS)
Mesh:
Year: 2017 PMID: 27886887 DOI: 10.1016/j.ncl.2016.08.003
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806